WHO-GMP Certified Commercial Pack · Product Code: AKP-007
Rabeprazole Sodium 20mg & Domperidone 10mg Tablets (Enteric Coated)
Formulation Overview: Fast-onset enteric-coated proton pump inhibitor and dopamine D2 antagonist tablet engineered for predictable intragastric acid suppression and coordinated upper GI motility. Formulated with Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg (20 mg + 10 mg) in Enteric-Coated Tablets dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-007 |
|---|---|
| Therapeutic Sector | Gastroenterology & PPIs |
| Dosage Form | Enteric-Coated Tablets |
| Active Ingredient | Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg |
| Strength / Purity | 20 mg + 10 mg |
| Clinical Indication | Acid reflux esophagitis, hyperacidity, bloating, and non-ulcer dyspepsia |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C, protect from moisture & direct sunlight |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |